SCHEMBL25568752

SCHEMBL25568752

Cc1ccccc1C(=O)N(C)N(C)C(=O)c1ccccc1C=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.50
ALDH1A1 P00352 2/20 0.50
KMT2A Q03164 3/20 0.47
MAPK1 P28482 1/20 0.42
LMNA P02545 2/20 0.39
MEN1 O00255 2/20 0.39
THRB P10828 1/20 0.39
BLM P54132 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
HPGD P15428 2/20 0.38
HTT P42858 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
ELANE P08246 1/20 0.37
TRIM24 O15164 1/20 0.37
TRIM33 Q9UPN9 1/20 0.37
ERCC5 P28715 1/20 0.37
FEN1 P39748 1/20 0.37
NPC1 O15118 1/20 0.36
SLC6A2 P23975 1/20 0.36
SLC6A4 P31645 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11216342 0.86 KMT2A (0.59) TSHRALDH1A1KMT2AMAPK1MEN1
SCHEMBL25567195 0.83 HSD11B1 (0.40) TSHRALDH1A1KMT2AMAPK1LMNA
SCHEMBL25567428 0.82 POLB (0.53) TSHRALDH1A1HPGDHTT
SCHEMBL1647150 0.80 MEN1 (0.52) TSHRALDH1A1KMT2ALMNAMEN1
SCHEMBL24250390 0.79 MEN1 (0.44) TSHRALDH1A1KMT2ALMNAMEN1
SCHEMBL14646679 0.79 ALDH1A1 (0.57) TSHRALDH1A1KMT2ALMNAMEN1
SCHEMBL25567408 0.78 LMNA (0.44) LMNASLC6A2SLC6A4SLC6A3
SCHEMBL25567804 0.78 NR4A1 (0.41) ALDH1A1KMT2AMAPK1LMNAMEN1
SCHEMBL18616928 0.77 MEN1 (0.43) TSHRALDH1A1KMT2ALMNAMEN1
SCHEMBL12205237 0.75 KMT2A (0.57) TSHRKMT2AMAPK1MEN1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023097386-A1 SELECTIVE HDAC6-INHIBITING N-ACYLHYDRAZONE COMPOUNDS, METHODS FOR PRODUCING SAME, COMPOSITIONS, USES, TREATMENT METHODS AND KITS EUROFARMA LABORATÓRIOS S.A (BR) 2023-06-08 WO disclosed